Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion type Assertion NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_head.
- NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion description "[Moreover, when XPD mutations prevent interaction with the p44 subunit of TFIIH, transactivation directed by certain nuclear receptors is inhibited, regardless of TTD versus XP phenotype, thus explaining the overlapping symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_provenance.
- NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion evidence source_evidence_literature NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_provenance.
- NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion SIO_000772 12820975 NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_provenance.
- NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion wasDerivedFrom befree-20140225 NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_provenance.
- NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_assertion wasGeneratedBy ECO_0000203 NP418963.RAna8nbPkguAmj8zQMXkmeVuUUSjyNvyh_duVvZ1KtnmQ130_provenance.